Concepts and challenges of biosimilars to mitigate the oncology drug expenses

Concepts and challenges of biosimilars to mitigate the oncology drug expenses

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2021.

Библиографические подробности
Главный автор:	Tania, Umme
Другие авторы:	Haque , Md. Aminul
Формат:	Диссертация
Язык:	en_US
Опубликовано:	Brac University 2021
Предметы:	Biosimilars Interchangeability Cancer therapy Monoclonal antibodies Biologic medicines Comparability exercise
Online-ссылка:	http://hdl.handle.net/10361/15111

Схожие документы

Biosimilar insulins: a potential option in the treatment of Diabetes
по: Tabassum, Turana
Опубликовано: (2022)

Targeted treatment in patients with non-small cell lung cancer: Use of Bevacizumab and its Biosimilars
по: Tania, Umme
Опубликовано: (2023)

Biosimilar in lymphoma treatment
по: Tanisha, Mehrin Haque
Опубликовано: (2021)

Advancement of Antibody-Drug conjugates in cancer treatment: A review
по: Sagar, Baejid Hossain
Опубликовано: (2022)

Biosimilars: A revolution for biologics in the pharmaceutical industry
по: Moreino, Shannon Sherwin
Опубликовано: (2018)

Immunotherapeutic approaches to treat cancer: Prospects and challenges
по: Fred, Namanda Rogers
Опубликовано: (2021)

Biologics and Biosimilars as Treatment Options for Psoriasis
по: Moya, Amena Khatun
Опубликовано: (2023)

Targeted therapeutic options in the treatment of Breast Cancer
по: Alam, Kazi Tasnuva
Опубликовано: (2022)

A review on targeted therapies for lung cancer
по: Ashraf, Anushey
Опубликовано: (2023)

Osteoarthritis: a multi-disciplinary factual review
по: Subah, Nowshin
Опубликовано: (2021)

Recent advancement of biologics in Asthma
по: Evan, Al- Shahriar
Опубликовано: (2022)

In vivo propagation of monoclonal antibodies in ascites fluid produced in BALB/c mice: characterization and diagnostic application for the identification of Vibrio cholerae O1
по: Chowdhury, Mashiat Nawar
Опубликовано: (2018)

A review on bispecific antibody (blinatumomab) for the treatment of acute lymphoblastic leukemia
по: Choki, Kinley
Опубликовано: (2024)

Post Covid-19 health indications of Covid-19 patients
по: Khan, Tanzim
Опубликовано: (2022)

PCSK9i: proprotein convertase subtilisin/kexin type 9 inhibitor a new phase of lipid-lowering treatment
по: Lubaba, Anikah
Опубликовано: (2024)

Pharmacokinetics, safety, efficacy and immunogenicity of Adalimumab biosimilar ABP-501in rheumatoid arthritis and plaque psoriasis
по: Akter, Anika
Опубликовано: (2022)

A review of next-generation immuno-oncology agents for cancer therapy: recent dictation shifts in cancer immunotherapy
по: Ratu, Tabassum
Опубликовано: (2024)

Trend in approval of targeted biologics in the last two decades
по: Siddika, Khadiza
Опубликовано: (2024)

A comprehensive review on drug repurposing in cancer treatment
по: Sarkar, Onusree
Опубликовано: (2024)

Drug repurposing: potential of Antimicrobial Drugs in Breast Cancer Treatment
по: Chakraborty, Anuradha
Опубликовано: (2024)

A review on the recent advancements on nanoparticles drug delivery approaches in anti-cancer treatment
по: Hoque, Syeda Mehren
Опубликовано: (2024)

An improved chromosome sorting algorithm by permutation group-based inverted block-interchanges
по: Tabassum, Afrida, и др.
Опубликовано: (2018)

Breast cancer therapy through Liposomal drug delivery system
по: Ome, Nusrat Jahan
Опубликовано: (2024)

Risk of cancer associated with antihypertensive drugs
по: Iqbal, Adnan
Опубликовано: (2024)

RIPK pathway, as a potential target, for cancer treatment - a review
по: Jahan, Nusrat
Опубликовано: (2024)

Study on anticancer drugs approved by the FDA from 2014 to 2023
по: Rattry, Faria Rahman
Опубликовано: (2024)

Clinical outcomes and safety comparison of gemcitabine plus cisplatin, capecitabine monotherapy, and gemcitabine plus oxaliplatin in the management of gallbladder carcinoma: a comprehensive meta-analysis
по: Rahman, Sanjida
Опубликовано: (2024)

Genetic innovations for breast cancer treatment : a review of gene therapy strategies and future implications
по: Hasan, Sakib
Опубликовано: (2024)

Immunotherapy in the Management of Lung Cancer
по: Tasnim, Humayra
Опубликовано: (2022)

Art therapy to improve quality of life of cancer patients and their carers in Bangladesh
по: Dowla, Rumana, и др.
Опубликовано: (2022)

Biosimilars
Опубликовано: (2013)

Biosimilars

Recent developments in the Adeno-Associated Viral Gene Therapy for Non-Small Cell Lung Cancer during the past 20 years
по: Razna, Amrin Islam
Опубликовано: (2019)

Therapeutic prospective of targeting calcium homeostasis in cancer – a review
по: Kamal, Tasnova
Опубликовано: (2019)

A review on carbon nanotube: a new era in cancer diagnosis & therapy
по: Parvez, Safi
Опубликовано: (2023)

An examination of therapeutic synergy: a comprehensive meta-analysis comparing the efficacy of TAS-102 and FOLFOX as a combination therapy for colon cancer
по: Hasan, Amit
Опубликовано: (2024)

Sugar based biopolymers in nanomedicine: a review
по: Juthy, Afrin Rahman
Опубликовано: (2024)

A review on combinatorial therapies in Melanoma
по: Ahmmed, Md. Kawsar
Опубликовано: (2024)

The impact of cell penetrating peptides in prospective cancer therapy: a review
по: Nashrah, Zannatul
Опубликовано: (2023)

Food, nutrition, physical activity and the prevention of cancer : a global perspective : a project of World Cancer Research Fund International.
Опубликовано: (2007)